Latest Breaking News On - F sanion se0005794617 - Page 1 : comparemela.com

PRESS RELEASE December 2, 2021 Saniona , a clinical stage biopharmaceutical company focused on rare diseases, today announced that the Chairman and the CEO, as well as additional members of the. | December 2, 2021

United statesTrista morrisonGlobenewswire incRami levinChief communications officerNasdaq stockholm small capSaniona ab publ stock exchangePress releaseF sanion se0005794617